Tim Coughlin

Tim Coughlin

Net worth: 3 M $ as of 30/06/2026

59 year
Health Technology
Commercial Services
Consumer Services

Profile

Timothy P.
Coughlin
is Chairman at aTyr Pharma, Inc. since 2024.
He is a Non-Executive Director at ADC Therapeutics SA starting in 2025.
He serves as an Independent Director at Travere Therapeutics, Inc. since 2015.
He is a Director at Vir Biotechnology, Inc. beginning in 2026.
Former roles include Independent Director at Fate Therapeutics, Inc. from 2015 to 2025, Director at Peloton Therapeutics, Inc. in 2019, Senior Manager-Health Sciences Practice at Ernst & Young LLP from 1989 to 1999, Chief Financial Officer at Neurocrine Biosciences, Inc., and Vice President-Financial Services at CommonSpirit Health from 1999 to 2002.
Education includes a graduate degree from San Diego State University conferred in 2002 and an undergraduate degree from Temple University (Pennsylvania) conferred in 1989.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2026 56,250 ( 0.06% ) 3 M $ 30/06/2026
03/06/2026 72,400 ( 0.06% ) 77 468 $ 30/06/2026
11/05/2026 56,000 ( 0.06% ) 33 432 $ 30/06/2026

Tim Coughlin active positions

CompaniesPositionStart
TRAVERE THERAPEUTICS, INC. Director/Board Member 31/03/2015
ATYR PHARMA, INC. Chairman 14/03/2024
ADC THERAPEUTICS SA Director/Board Member 01/06/2025
VIR BIOTECHNOLOGY, INC. Director/Board Member 09/06/2026

Former positions of Tim Coughlin

CompaniesPositionEnd
FATE THERAPEUTICS, INC. Director/Board Member 29/05/2025
PELOTON THERAPEUTICS, INC. Director/Board Member 01/12/2019
Director of Finance/CFO 01/01/2002
Corporate Officer/Principal 01/01/1999
NEUROCRINE BIOSCIENCES, INC. Director of Finance/CFO -
See the detail of Tim Coughlin's experience

Training of Tim Coughlin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology